Cefuroxime for Acute Otitis Media

Primary Recommendation

• The World Health Organization recommends against using cefuroxime as a first-line or second-line agent for acute otitis media, reserving it for alternative treatment in penicillin-allergic patients 1, 2, 3

Current Guideline Position

• The World Health Organization guidelines explicitly exclude cefuroxime from recommended treatment options for acute otitis media to reduce emphasis on routinely treating penicillin-resistant Streptococcus pneumoniae, favor oral options with narrower spectrum, and promote antimicrobial stewardship by limiting Watch category antibiotics 1

Recommended Treatment Algorithm

First-Line Treatment

• The American Academy of Pediatrics recommends amoxicillin 80-90 mg/kg/day divided into 2 doses as the first-line treatment for acute otitis media due to its effectiveness, safety, low cost, acceptable taste, and narrow spectrum 2, 3

Second-Line Treatment

• The American Academy of Pediatrics recommends amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day clavulanate in 2 divided doses) as a second-line treatment for acute otitis media when amoxicillin is not appropriate 1, 2, 3

Penicillin Allergy Alternative

• The American Academy of Pediatrics recommends cefuroxime axetil 30 mg/kg/day in 2 divided doses as an alternative treatment for acute otitis media in patients with a non-type I penicillin allergy 2, 3, 5

Reassessment Criteria

• The American Academy of Pediatrics recommends evaluating treatment response at 48-72 hours and switching to ceftriaxone (50 mg IM/IV for 3 days) or considering tympanocentesis if there is no improvement on cefuroxime 2, 6, 4